Drug Clinical Supply Agreement and Exclusive Cross-License Agreement Sample Contracts

SECOND AMENDMENT TO DRUG CLINICAL SUPPLY AGREEMENT AND THIRD AMENDMENT TO EXCLUSIVE CROSS-LICENSE, TECHNOLOGY TRANSFER, AND REGULATORY MATTERS AGREEMENT

Drug Clinical Supply Agreement and Exclusive Cross-License Agreement • January 12th, 2016 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations

• Contract Type
  Drug Clinical Supply Agreement and Exclusive Cross-License Agreement
• Filed
  January 12th, 2016
• Company
  Bellerophon Therapeutics, Inc.
• Industry
  Pharmaceutical preparations

THIS SECOND AMENDMENT TO DRUG CLINICAL SUPPLY AGREEMENT AND THIRD AMENDMENT TO EXCLUSIVE CROSS-LICENSE, TECHNOLOGY TRANSFER, AND REGULATORY MATTERS AGREEMENT (this “Amendment”) is entered into the later of the dates in the signature block below (the “Amendment Effective Date”) by and between INO Therapeutics LLC, a Delaware limited liability company having a place of business at Perryville III Corporate Park, 53 Frontage Road, Third Floor, Hampton, NJ 08827 (“Ikaria”), and Bellerophon Pulse Technologies LLC, a Delaware limited liability company, with offices at 184 Liberty Corner Road, Suite 302, Warren, NJ 07059 (“Pulse Technologies”).